Characterizing Longitudinal Melanonychia in Skin of Color [0.03%]
肤色皮肤 longitudinal melanonychia 的特征分析
Zasca-Aisha Ristianto,Derek Maas,Luc Thomas et al.
Zasca-Aisha Ristianto et al.
Sigrun Alba Johannesdottir Schmidt,Therese Koops Grønborg,Sigrid Bjerge Gribsholt et al.
Sigrun Alba Johannesdottir Schmidt et al.
Importance: Isotretinoin is an effective treatment for moderate to severe acne, but concerns exist that exposure during adolescence could impair linear growth. ...
Skin Cancer Risk Profile of Asymptomatic Patients Seeking Periodic Skin Examinations for Skin Cancer Concerns [0.03%]
无症状求诊进行皮肤癌筛查患者的风险特征分析
Yin Li,Robert A Swerlick
Yin Li
Importance: Periodic comprehensive skin examinations of asymptomatic individuals are widely accepted by dermatologists and the public, resulting in deployment of skin cancer (SC) surveillance practices that may include pa...
Yi-Kuan Chiang,Ding-Dar Lee
Yi-Kuan Chiang
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial [0.03%]
伊克珠单抗联合或不联合 tirzepatide 治疗银屑病成年患者合并超重或肥胖的 IIIb 期随机临床试验
Mark Lebwohl,Andrew Blauvelt,Cynthia E Kartman et al.
Mark Lebwohl et al.
Importance: Overweight and obesity affect 60% to 78% of patients with psoriasis, affecting disease severity, treatment response, and clinical outcomes. However, no large, randomized, active-controlled clinical trial has e...
William Liu,Angela J Luo,Winston Liu et al.
William Liu et al.
Targeting Cardiometabolic Disease to Improve Psoriasis-A New Treatment Paradigm Emerges [0.03%]
以改善银屑病为目标治疗心血管代谢性疾病——新的治疗模式应运而生
Michael S Garshick,Joel M Gelfand
Michael S Garshick
Text Messaging for Cardiovascular Risk Prevention in Psoriasis: A Randomized Clinical Trial [0.03%]
银屑病患者心血管风险防护的文本消息干预试验
Annika Smith,Ishana Dixit,Lois Zhang et al.
Annika Smith et al.
Importance: Cardiovascular disease (CVD) is the leading cause of mortality in patients with psoriasis, yet structured CVD prevention is not routinely embedded in dermatology care. ...
Digital Intradermal Hyaluronidase Injections for Sclerodactyly in Systemic Sclerosis [0.03%]
用于系统性硬化症屈指畸形的数字皮内透明质酸酶注射疗法
Maureen Whittelsey,Arjun Mahajan,Keyarah Grullon et al.
Maureen Whittelsey et al.
Intraocular Pressure During Short-Term Topical or Systemic Corticosteroid Treatment: Analysis of 3 Randomized Clinical Trials [0.03%]
短期局部或全身糖皮质激素治疗的眼内压变化：3项随机临床试验的分析
Diva Amiri,Pernille H Hellmann,Jacob P Thyssen et al.
Diva Amiri et al.
Importance: Increased intraocular pressure (IOP) is a known adverse effect of corticosteroid use and may lead to corticosteroid-induced glaucoma. However, clinical evidence on the impact of topical corticosteroids (TCS) o...